second cancer non-hodgkin lymphoma risk second malign non-hodgkin lymphoma nhl patient nhl area nation cancer institut surveil epidemiolog end result program compar gener popul nhl patient risk second cancer o/e o/e ratio time survivor signific excess acut nonlymphocyt leukemia o/e cancer bladder o/e kidney o/e lung o/e malign melanoma o/e hodgkin diseas o/e chemotherapi subsequ acut nonlymphocyt leukemia anll bladder cancer radiat therapi anll cancer lung bladder bone malign melanoma initi nhl treatment 